Aryl hydrocarbon receptor protects against bacterial infection by promoting macrophage survival and reactive oxygen species production

International Immunology

Volumn 26, Issue 4, 2014, Pages 209-220

  Kimura, Akihiro ^a,b   Abe, Hiromi ^a,c   Tsuruta, Sanae ^a,b   Chiba, Sayuri ^a,b   Fujii Kuriyama, Yoshiaki ^d   Sekiya, Takashi ^a,b   Morita, Rimpei ^a,b   Yoshimura, Akihiko ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis inhibitor of macrophages; Dioxin receptor; Innate immunity; Listeria monocytogenes

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; AUTACOID; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GROWTH; CELL DEATH; CELL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; IN VITRO STUDY; INNATE IMMUNITY; LISTERIOSIS; MACROPHAGE; MORTALITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; BACTERIAL LOAD; C57BL MOUSE; CELL CULTURE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY;

ANIMALS; APOPTOSIS; BACTERIAL LOAD; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; INFLAMMATION MEDIATORS; LISTERIOSIS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REACTIVE OXYGEN SPECIES; RECEPTORS, ARYL HYDROCARBON;

EID: 84897515710     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt067     Document Type: Article

References (44)

1. Burbach, K. M., Poland, A. and Bradfield, C. A. 1992. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl Acad. Sci. USA 89:8185.
2. Ema, M., Sogawa, K., Watanabe, N. et al. 1992. cDNA cloning, and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184:246.
3. Fujii-Kuriyama, Y., Ema, M., Mimura, J., and Sogawa, K. 1994. Ah receptor: a novel ligand-activated transcription factor. Exp. Clin. Immunogenet. 11:65.
4. Dragan, Y. P., and Schrenk, D. 2000. Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion. Food Addit. Contam. 17:289.
5. Ohtake, F., Takeyama, K., Matsumoto, T. et al. 2003. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423:545.
6. Puga, A., Tomlinson, C. R., and Xia, Y. 2005. Ah receptor signals cross-talk with multiple developmental pathways. Biochem. Pharmacol. 69:199.
7. Ohtake, F., Baba, A., Takada, I. et al. 2007. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446:562.
8. Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y., and Kishimoto, T. 2008 Aryl hydrocarbon receptor regulates Stat1 activation, and participates in the development of Th17 cells. Proc. Natl Acad. Sci. USA. 105:9721.
9. Quintana, F. J., Basso, A. S., Iglesias, A. H. et al. 2008. Control of T(reg), and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:65.
10. Veldhoen, M., Hirota, K., Westendorf, A. M. et al. 2008. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453:106.
11. Apetoh, L., Quintana, F. J., Pot, C. et al. 2010. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11:854.
12. Kimura, A., Naka, T., Nakahama, T. et al. 2009. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J. Exp. Med. 206:2027.
13. Nguyen, N. T., Kimura, A., Nakahama, T. et al. 2010. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl Acad. Sci. USA 107:19961.
14. Lee, J. S., Cella, M., McDonald, K. G. et al. 2012. AHR drives the development of gut ILC22 cells, and postnatal lymphoid tissues via pathways dependent on, and independent of Notch. Nat. Immunol. 13:144.
15. Buchmeier, N. A., and Schreiber, R. D. 1985. Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proc. Natl Acad. Sci. USA 82:7404.
16. Havell, E. A. 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894.
17. Kelly, J. P., and Bancroft, G. J. 1996. Administration of interleukin- 10 abolishes innate resistance to Listeria monocytogenes. Eur. J. Immunol. 26:356.
18. Meeks, K. D., Sieve, A. N., Kolls, J. K., Ghilardi, N., and Berg, R. E. 2009. IL-23 is required for protection against systemic infection with Listeria monocytogenes. J. Immunol. 183:8026.
19. Graham, A. C., Carr, K. D., Sieve, A. N., Indramohan, M., Break, T. J., and Berg, R. E. 2011. IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection. PLoS One 6:e17171.
20. Joseph, S. B., Bradley, M. N., Castrillo, A. et al. 2004. LXRdependent gene expression is important for macrophage survival, and the innate immune response. Cell 119:299.
21. Shi, L. Z., Faith, N. G., Nakayama, Y., Suresh, M., Steinberg, H., and Czuprynski, C. J. 2007. The aryl hydrocarbon receptor is required for optimal resistance to Listeria monocytogenes infection in mice. J. Immunol. 179:6952.
22. Esser, C., Rannug, A., and Stockinger, B. 2009. The aryl hydrocarbon receptor in immunity. Trends Immunol. 30:447.
23. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4:812.
24. Machata, S., Tchatalbachev, S., Mohamed, W., Jänsch, L., Hain, T., and Chakraborty, T. 2008. Lipoproteins of Listeria monocytogenes are critical for virulence, and TLR2-mediated immune activation. J. Immunol. 181:2028.
25. Edelson, B. T., and Unanue, E. R. 2002. MyD88-dependent but tolllike receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169:3869.
26. Inohara, N., and Nuñez, G. 2003. NODs: intracellular proteins involved in inflammation, and apoptosis. Nat. Rev. Immunol. 3:371.
27. Lambeth, J. D. 2004. NOX enzymes, and the biology of reactive oxygen. Nat. Rev. Immunol. 4:181.
28. Wada, T., Sunaga, H., Ohkawara, R., and Shimba, S. 2013. Aryl hydrocarbon receptor modulates NADPH oxidase activity via direct transcriptional regulation of p40phox expression. Mol. Pharmacol. 83:1133.
29. Hamada, S., Umemura, M., Shiono, T. et al. 2008. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J. Immunol. 181:3456.
30. Willis, S., Day, C. L., Hinds, M. G., and Huang, D. C. 2003. The Bcl-2-regulated apoptotic pathway. J. Cell Sci. 116(Pt 20):4053.
31. Boutros, P. C., Moffat, I. D., Franc, M. A. et al. 2004. Dioxinresponsive AHRE-II gene battery: identification by phylogenetic footprinting. Biochem. Biophys. Res. Commun. 321:707.
32. Chandra, J., Samali, A., and Orrenius, S. 2000. Triggering, and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 29:323.
33. D'Cruz, D. 2000. Autoimmune diseases associated with drugs, chemicals, and environmental factors. Toxicol. Lett. 112:421.
34. Nguyen, L. T., Ramanathan, M., Weinstock-Guttman, B. et al. 2000. Detection of cytochrome P450, and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays. Drug Metab. Dispos. 28:987.
35. Naldi, L., Chatenoud, L., Linder, D. et al. 2005. Cigarette smoking, body mass index,, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J. Invest. Dermatol. 125:61.
36. Kobayashi, S., Okamoto, H., Iwamoto, T. et al. 2008. A role for the aryl hydrocarbon receptor, and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxford) 47:1317.
37. Klareskog, L., Catrina, A. I., and Paget, S. 2009. Rheumatoid arthritis. Lancet 373:659.
38. Vorderstrasse, B. A., and Lawrence, B. P. 2006. Protection against lethal challenge with Streptococcus pneumoniae is conferred by aryl hydrocarbon receptor activation but is not associated with an enhanced inflammatory response. Infect. Immun. 74:5679.
39. Kopp, E., and Medzhitov, R. 2003. Recognition of microbial infection by toll-like receptors. Curr. Opin. Immunol. 15:396.
40. Strober, W., Murray, P. J., Kitani, A., and Watanabe, T. 2006. Signalling pathways, and molecular interactions of NOD1, and NOD2. Nat. Rev. Immunol. 6:9.
41. O'Connell, R. M., Saha, S. K., Vaidya, S. A. et al. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200:437.
42. Haruta, I., Kato, Y., Hashimoto, E. et al. 2001. Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival, and enhancing phagocytotic function of macrophages. J. Biol. Chem. 276:22910.
43. Ma, Q., Kinneer, K., Bi, Y., Chan, J. Y., and Kan, Y. W. 2004. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor), and Nrf2 signal transduction. Biochem. J. 377(Pt 1):205.
44. Köhle, C., and Bock, K. W. 2007. Coordinate regulation of phase I, and II xenobiotic metabolisms by the Ah receptor, and Nrf2. Biochem. Pharmacol. 73:1853.